Cargando…

Identification and Validation of Long Non-Coding RNA LCIIAR as a Biomarker in LUAD

Lung cancer is the leading cause of cancer-related death worldwide. Therapies for lung cancer have relatively poor outcomes and need to be improved. Lung cancer immune cell infiltration associated RNA (LCIIAR) is a long noncoding RNA (lncRNA), which is overexpressed in human cancers. However, the cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Wenjun, Yuan, Yixiao, Chen, Xi, Zhai, Haoqing, An, Yin, Tang, Lin, Wang, Juan, Zhang, Dahang, Zhang, Liren, Cheng, Wanli, Wang, Xin, Duan, Lincan, Mutti, Luciano, Han, Bin, Wang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293053/ https://www.ncbi.nlm.nih.gov/pubmed/35860557 http://dx.doi.org/10.3389/fonc.2022.933071

Ejemplares similares

Long Non-Coding RNA-TMPO-AS1 as ceRNA Binding to let-7c-5p Upregulates STRIP2 Expression and Predicts Poor Prognosis in Lung Adenocarcinoma
por: Wang, Juan, et al.
Publicado: (2022)

Corrigendum: Long non-coding RNA-TMPO-AS1 as ceRNA binding to let-7c-5p upregulates STRIP2 expression and predicts poor prognosis in lung adenocarcinoma
por: Wang, Juan, et al.
Publicado: (2022)

Identification and Validation Prognostic Impact of MiRNA-30a-5p in Lung Adenocarcinoma
por: Jiang, Xiulin, et al.
Publicado: (2022)

Corrigendum: Identification and Validation Prognostic Impact of miRNA-30a-5p in Lung Adenocarcinoma
por: Jiang, Xiulin, et al.
Publicado: (2022)

Deciphering the Role of Shugoshin-Like Protein 1 in Lung Adenocarcinoma: A Comprehensive Analysis and In Vitro Study
por: Yuan, Yixiao, et al.
Publicado: (2022)

NcRNA-Mediated High Expression of HMMR as a Prognostic Biomarker Correlated With Cell Proliferation and Cell Migration in Lung Adenocarcinoma
por: Jiang, Xiulin, et al.
Publicado: (2022)

Immune-Related miRNA-195-5p Inhibits the Progression of Lung Adenocarcinoma by Targeting Polypyrimidine Tract-Binding Protein 1
por: Duan, Lincan, et al.
Publicado: (2022)

MicroRNA-125b-5p Correlates With Prognosis and Lung Adenocarcinoma Progression
por: Tang, Lin, et al.
Publicado: (2022)

Systematic Analysis and Validation of the Prognosis, Immunological Role and Biology Function of the Ferroptosis-Related lncRNA GSEC/miRNA-101-3p/CISD1 Axis in Lung Adenocarcinoma
por: Jiang, Xiulin, et al.
Publicado: (2022)

MDFI is a novel biomarker for poor prognosis in LUAD
por: Chen, Pengyu, et al.
Publicado: (2022)

Case Report: Afatinib Sensitivity in Rare EGFR E746_L747delinsIP Mutated LUAD With Peritoneal Metastases
por: Zhang, Lili, et al.
Publicado: (2022)

Comprehensive Analyses of the Immunological and Prognostic Roles of an IQGAP3AR/let-7c-5p/IQGAP3 Axis in Different Types of Human Cancer
por: Yuan, Yixiao, et al.
Publicado: (2022)

The function and clinical implication of circular RNAs in lung cancer
por: Ren, Wenjun, et al.
Publicado: (2022)

FOXM1/lncRNA TYMSOS/miR-214-3p–Mediated High Expression of NCAPG Correlates With Poor Prognosis and Cell Proliferation in Non–Small Cell Lung Carcinoma
por: Yuan, Yixiao, et al.
Publicado: (2022)

Identification of Key Pathways and Genes Related to Immunotherapy Resistance of LUAD Based on WGCNA Analysis
por: Yu, Weina, et al.
Publicado: (2022)

KRT8 Serves as a Novel Biomarker for LUAD and Promotes Metastasis and EMT via NF-κB Signaling
por: Chen, Hao, et al.
Publicado: (2022)

Over-Expression of Long Non-Coding RNA-AC099850.3 Correlates With Tumor Progression and Poor Prognosis in Lung Adenocarcinoma
por: Chen, Xi, et al.
Publicado: (2022)

MCM4 acts as a biomarker for LUAD prognosis
por: Tan, Yue, et al.
Publicado: (2023)

Intratumor heterogeneity of driver mutations and TMB distribution in 30 early-stage LUAD patients with multiple lesions
por: Qiu, Yuan, et al.
Publicado: (2022)

Membrane tension sensing molecule-FNBP1 is a prognostic biomarker related to immune infiltration in BRCA, LUAD and STAD
por: Wang, Zixuan, et al.
Publicado: (2022)

MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma
por: Yang, Shu, et al.
Publicado: (2022)

The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC
por: Fu, Linhai, et al.
Publicado: (2020)

PBK correlates with prognosis, immune escape and drug response in LUAD
por: Ma, Hongyu, et al.
Publicado: (2023)

Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC
por: Wang, Yu, et al.
Publicado: (2023)

Linc00996 is a favorable prognostic factor in LUAD: Results from bioinformatics analysis and experimental validation
por: Shen, Zhenghai, et al.
Publicado: (2022)

Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Lung Adenocarcinoma by Comprehensive Bioinformatics Analysis and In Vitro Study
por: Li, Xinyan, et al.
Publicado: (2022)

Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression
por: Chen, Xi, et al.
Publicado: (2022)

Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma
por: Chen, Xi, et al.
Publicado: (2022)

Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases
por: Zheng, Qiangqiang, et al.
Publicado: (2021)

RETSAT Mutation Selected for Hypoxia Adaptation Inhibits Tumor Growth
por: Jiang, Xiulin, et al.
Publicado: (2021)

The Clinical Prediction Value of the Ubiquitination Model Reflecting the Immune Traits in LUAD
por: Che, Yinggang, et al.
Publicado: (2022)

NF-YA Overexpression in Lung Cancer: LUAD
por: Bezzecchi, Eugenia, et al.
Publicado: (2020)

Oxidative Stress-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Responses in Patients With LUAD
por: Sun, Xinti, et al.
Publicado: (2022)

Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD
por: Chen, Hang, et al.
Publicado: (2021)

STK24 Promotes Progression of LUAD and Modulates the Immune Microenvironment
por: Li, Yadong, et al.
Publicado: (2023)

Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance
por: Zhang, Ling, et al.
Publicado: (2020)

Editorial: Prognostic factors in non-small cell lung cancer
por: Rahouma, Mohamed, et al.
Publicado: (2023)

Long Non-Coding RNAs as Potential Diagnostic and Prognostic Biomarkers in Breast Cancer: Progress and Prospects
por: Lu, Cuicui, et al.
Publicado: (2021)

Comprehensive Analysis of the Prognostic and Immunological Role of PAFAH1B in Pan-Cancer
por: Yuan, Yixiao, et al.
Publicado: (2022)

Editorial: Editor's challenge: Dr. Luciano Mutti - what is the true impact of ICIs on survival in the treatment of thoracic malignancies?
por: Mutti, Luciano, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kct1l565td5g3cs50npihao3nr